Control of Tissue Fibrosis by 5-Methoxytryptophan, an Innate Anti-Inflammatory Metabolite
Tissue fibrosis causes debilitating human diseases such as liver cirrhosis, heart failure, chronic kidney disease and pulmonary insufficiency. It is a dynamic process orchestrated by specific subsets of monocyte-macrophages, fibroblasts, pericytes and hepatic stellate cells. Fibrosis is linked to ti...
Guardado en:
Autor principal: | Kenneth K Wu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bed014173b834a0b8b8103a795a28c8a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TRPV4 Mechanotransduction in Fibrosis
por: Ravi K. Adapala, et al.
Publicado: (2021) -
Restoration of 5-methoxytryptophan protects against atherosclerotic chondrogenesis and calcification in ApoE −/− mice fed high fat diet
por: Guan-Lin Lee, et al.
Publicado: (2021) -
Obesidad: factor de riesgo para esteatohepatitis y fibrosis hepática
por: Poniachik T,Jaime, et al.
Publicado: (2002) -
Blancos terapéuticos potenciales para revertir la cirrosis hepática
por: García B,Leonel, et al.
Publicado: (2007) -
Association of Tumor Hydroxyindole O-Methyltransferase and Serum 5-Methoxytryptophan with Long-Term Survival of Hepatocellular Carcinoma
por: Bor-Sheng Ko, et al.
Publicado: (2021)